Company news
TSO3 Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer
September 25, 2017
TSO3 Provides an Update on Recent Activities
September 7, 2017
TSO3 Comments on Unusual Trading Activities
August 23, 2017
TSO3 Reports Record Second Quarter 2017 Results
August 1, 2017
TSO3 Sets Second Quarter Earnings Call for Wednesday, August 2, 2017 at 8: 30 a.m. EDT
July 24, 2017
TSO3 Files for an Extended Claim for Duodenoscopes
July 20, 2017
TSO3 Expands Duodenoscope Regulatory Filing Strategy
June 14, 2017
TSO3 announces the Vote Results from its Annual Meeting of the Shareholders
May 11, 2017
TSO3 Reports Record First Quarter 2017 Results
May 10, 2017
TSO3 to Report First Quarter 2017 Results and Hold Annual Meeting of Shareholders on Wednesday, May 10, 2017
April 26, 2017
TSO3 to publish innovative validation method linked to sterilization of multichannel endoscopes in upcoming issue of the Canadian Journal of Infection Control
April 19, 2017
TSO3 Reports Record Fourth Quarter and Full Year 2016 Results
March 21, 2017
TSO3 Sets Fourth Quarter and Full Year 2016 Earnings Call for Tuesday, March 21, 2017 at 10: 30 a.m. EDT
March 7, 2017
TSO3 Appoints Dr. Linda Rosenstock and Mr. Jeffrey Pompeo to its Board of Directors
February 16, 2017
TSO3 Appoints Mark Pasmore as Vice President of Research and Development
February 2, 2017
TSO3 Welcomes The Medical University of South Carolina to its Strategic Partner Facility Program
January 26, 2017
TSO3 Welcomes The Medical University of South Carolina to its Strategic Partner Facility Program
January 25, 2017
TSO3 Provides an Operational Update
January 5, 2017
TSO3 adds the University of Rochester Medical Center to its Strategic Partner Facility Program
January 5, 2017
TSO3 Enters into Strategic Partner Facility Agreement with The Mount Sinai Hospital
December 23, 2016
TSO3 Secures Access to Non-Dilutive Growth Capital Through Receivables Factoring
December 22, 2016
TSO3 Receives 2017 Purchase Orders from Getinge
December 2, 2016
TSO3 Reports Third Quarter 2016 Results
November 7, 2016
TSO3 to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum on November 17, 2016
October 27, 2016
TSO3 Sets Third Quarter 2016 Conference Call for Monday, November 7, 2016 at 10: 30 a.m. EST
October 25, 2016
TSO3 to Present at the 5th Annual Liolios Gateway Conference on September 7th, 2016
August 24, 2016
TSO3 to Present at Upcoming Investor Conferences
August 4, 2016
TSO3 Reports Second Quarter 2016 Results
August 3, 2016
TSO3 Simplifies Sterilization of Complete Heavy-Duty, Battery-Powered Orthopedic Instrument Sets
July 25, 2016
TSO3 Sets Second Quarter 2016 Conference Call for Wednesday, August 3, 2016 at 10: 30 a.m. EDT
July 20, 2016
TSO3 Prepares for European Product Launch
July 18, 2016
TSO3 Receives U.S. Clearance for Extended Claims for Its Breakthrough Medical Device Sterilizer
July 4, 2016
TSO3 Responds to U.S. Regulators on Extended Claims and Provides Operations Update
June 1, 2016
Canadian Journal of Infection Control to Publish Paper on TSO3's STERIZONE® VP4 Sterilizer
May 18, 2016
TSO3 announces the Results of the Votes from its Annual and Special Meeting of the Shareholders
May 5, 2016
TSO3 Reports Record First Quarter 2016 Results
May 4, 2016
TSO3 to Report First Quarter 2016 Results and Hold Annual General and Special Meeting of Shareholders on Wednesday, May 4, 2016
April 26, 2016
TSO3 to Present at Bloom Burton & Co. Healthcare Investor Conference on May 2, 2016
April 18, 2016
TSO3 Receives FDA 510(k) Clearance for Universal Design of STERIZONE® VP4 Sterilizer
March 28, 2016
TSO3 Reports Fourth Quarter and Full Year 2015 Results
March 23, 2016
TSO3 Provides Update on Extended U.S. Claims Filed for Breakthrough Medical Device Sterilizer
March 14, 2016
TSO3 to Present at the 28th Annual ROTH Conference on March 16, 2016
March 10, 2016
TSO3 Sets Fourth Quarter and Full Year 2015 Earnings Call for Wednesday, March 23, 2016 at 10: 30 a.m. EDT
March 9, 2016
TSO3 Provides Operations Update - Recruiting, Supplier Relationships and Improved Process Flow All Contributing to Increased Production Rates and Shipments
February 25, 2016
TSO3 Announces $13.5 million in Warrant Proceeds
February 8, 2016
TSO3 Appoints Harold R. Tessman as COO
January 27, 2016
TSO3 Accelerates Warrant Expiry Date
January 5, 2016
TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
December 22, 2015
TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
December 21, 2015
TSO3 Appoints Glen Kayll as Chief Financial Officer
December 18, 2015
Decks
The 5 newest of 41 decks. Every deck is listed under its year.
- Investor Presentation (May 2019)
Investor deck · 19 slides · May 2019
- Investor Presentation (May 2019)
Investor deck · 19 slides · May 2019
- Investor Presentation (November 2018)
Investor deck · 20 slides · November 2018
- Investor Presentation (November 2018)
Investor deck · 20 slides · November 2018
- Investor Presentation (May 2018)
Investor deck · 18 slides · May 2018